FindTrial
Sign In

Homoeopathy In Polycystic Ovarian Syndrome

Utility Of Essential Synthesis Repertory In Polycystic Ovarian Syndrome - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091943
Enrollment
30
Registered
2025-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicines: Individualized Homoeopathic Medicines Will Be Prescribed On The Basis Of Totality Of Symptoms And Individual Susceptibility The Medicine Will Be A

Sponsors

C D Pachchigar College Of Homeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All The Socio-economical Class Will Be Included 2 Women Age 14 To 45 Years

Exclusion criteria

Exclusion criteria: Patient Require Surgical Intervention

Design outcomes

Primary

MeasureTime frame
To Find The Utility Of Essential Synthesis Repertory In Polycystic Ovarian SyndromeTimepoint: 9 Months—

Secondary

MeasureTime frame
To Study The Role Of Homoeopathic Treatment In Polycystic Ovarian SyndromeTimepoint: 9 Months—

Countries

India

Contacts

Public ContactDr Niloufer Pachchigar

C D Pachchigar College Of Homeopathic Medicine And Hospital

drpachchigar@gmail.com9925556888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026